Работы, цитирующие эту работу

Работ: 2

Работа: A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants

1. COVID-19 Vaccines - Current State and Perspectives

   Ibrokhim Y. Abdurakhmonov

   КнигаSARS-CoV-2 and COVID-19 ResearchIntechOpen eBooks2022Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.451741

2. Coronavirus spike protein-based vaccines. Vaccine delivery systems

   Akmal M. Asrorov, Mirzakamol S. Ayubov, Bin Tu +6

   СтатьяSARS-CoV-2 and COVID-19 ResearchMedicine in Drug Discovery2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.article.002427